Digestion

Original Paper

Changes in Gastro-Intestinal Motility Induced by Cholera Toxin and Experimental Osmotic Diarrhoea in Dogs: Effects of Treatment with an Argillaceous Compound

Fioramonti J. · Droy-Lefaix M.T. · Buéno L.

Author affiliations

Laboratoire de Pharmacologie-Toxicologie, INRA, Toulouse, France

Related Articles for ""

Digestion 1987;36:230–237

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: May 26, 1986
Published online: January 30, 2009
Issue release date: 1987

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0

ISSN: 0012-2823 (Print)
eISSN: 1421-9867 (Online)

For additional information: https://www.karger.com/DIG

Abstract

Effects on digestive motility of two agents which induce diarrhoea were investigated in conscious dogs chronically fitted with strain-gauge transducers sutured to the serosa of the antrum, the jejunum and the proximal colon and with a catheter inserted into the duodenum. Effects were tested before, during and after treatment with an argillaceous compound, smectite, at a dose of 100 mg/kg/day for 6 days. Smectite treatment alone induced only minor changes in gastric motility with a decrease in the motility index and an increase in the duration of the post-prandial disruption of gastric migrating motor complexes (MMCs). Intraduodenal administration of cholera toxin (200 μg) before smectite treatment disrupted MMCs on the stomach and the jejunum for more than 10 h without affecting colonic motility. These effects were still seen when cholera toxin was administered on the 3rd day of smectite treatment but were partially antagonized on the 6th day of treatment. Intraduodenal infusion of a hypertonic mannitol solution (900 mosm/l, 6 ml/min for 1 h) transiently disrupted gastric and jejunal MMCs, stimulating colonic motility for more than 6 h and inducing abundant diarrhoea 45–60 min after the beginning of the infusion. When the mannitol infusion was repeated on the 3rd and 6th days of smectite, gastric and jejunal motor disturbances persisted while colonic hyperactivity was abolished and onset of diarrhoea was delayed by more than 8 h. We thus conclude that smectite treatment has an antidiarrhoeal effect, partially antagonizing digestive motor disturbances induced by two agents used to provoke experimental diarrhoea.

© 1987 S. Karger AG, Basel




Related Articles:


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: May 26, 1986
Published online: January 30, 2009
Issue release date: 1987

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0

ISSN: 0012-2823 (Print)
eISSN: 1421-9867 (Online)

For additional information: https://www.karger.com/DIG


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP